Current therapy of multiple sclerosis.
The list of medications for both immune modulation and symptomatic relief continues to grow. Ideally, however, drug therapy should be part of a multidisciplinary approach that also includes such elements as patient education and physical therapy.
Johnson
K P
KP
Department of Neurology, University of Maryland School of Medicine, Baltimore, USA.
Baringer
J R
JR
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000465:Algorithms; D001921:Brain / Q000473:pathology; D004032:Diet; D015444:Exercise; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000276:Adjuvants, Immunologic; D007370:Interferon Type I; D010455:Peptides; D011994:Recombinant Proteins; D000068717:Glatiramer Acetate